Mannosylated Butyrophilin Tumour Markers

This invention relates to the finding that butyrophilins (BTNs) are mannosylated when expressed by cancer cells. Methods and compositions relating to the detection and treatment of cancer cells expressing mannosylated butyrophilins (BTNs) are provided.

Patents:
WO 2,009,030,884

Inventor(s): TROWSDALE JOHN [GB]; MALCHEREK GEORG [DE]

Type of Offer: Sale



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent